» QuiaPEG CEO Marcus Bosson on the issue
» Annexin Pharmaceuticals on the new indication cancer
» Interesting innovations at Feminvest's annual event
» BioStock Investor Meeting starts today at 10.00:XNUMX
» Pfizer acquires Seagen for $43 billion
Read BioStock's newsletter for v.11 here.
Watch this week's episode of The IPO round in the banner below:
On March 16th, we broadcast the first digital event of the year – BioStock Investor Meeting – with representatives from a number of life science companies. Watch the event again here via the banner below.
Morning news
Lipums vd Einar Ponten comments on the interim report and year-end report in a live webcast on March 24. Read more.
Carbiotix develops a new CarbiAXOS process that doubles production. Read more.
Annex appoints Susanne Andersson to the CFO. Read more.
Scandion Oncology invites you to a webcast of the publication of the year-end report on March 28. Read more.
Alzinova applies for a patent for the antibody ALZ-20. Read more. The Analysis Guide has published an analysis of the company. Read more.
PHI creates subsidiary for the expected EU patent regarding synthetic antibodies. Read more.
PolarCool decides on a directed new share issue of up to SEK 1,5 million. Read more.
Episurf Medical presenting at Redeye event. Read more.
DanCann Pharma carries out a directed new share issue. Read more.
Sobi announces results from the phase III DISSOLVE program with SEL 212. Read more.
Subscription period in Tendonitis Rights issue begins today. Read moreThe company has published a memorandum in connection with the issue. Read more.
Kancera announces that a process patent has been issued in Japan. Read more.
Medfield Diagnostics signs a cooperation agreement with Allytec regarding the Nordic market. Read more.
iCellate is included as a partner in the Metro study for the analysis of circulating tumor cells (CTCs) in prostate cancer. Read more.
The Oncology Company Cytovation appoints Iman Barilero to Chief Development Officer. Read more.
Medim extends the contract with Ostrobothnia Welfare Area. Read more.
Ambi is organizing a capital markets day today. Read more.
Orthoma presents at capital markets days. Read more.
SDS Life Science is recruiting a consultant in clinical development in Uppsala. Read more.
Changes in equity and number of votes:
News since monthlunch
WntResearchs vd Pernilla Sandwall presents the company at the Mangold Insight investor day on March 22. Read more.
BrainCool has received CB certificate for a new generation of RhinoChill System. Read more.
RLS Globals ChloraSolv shows significantly higher antibiofilm activity in vitro compared to other debridement products in a recently published article. Read more.
Amarin has presented new data showing significant efficacy with Vazkepa (icosapentethyl). Read more.
Diagonal Bio announces results from an external study. Read more.
Detection Technology joins a research consortium to develop detectors for new medical imaging. Read more.
Allarity Therapeutics doses first patient in phase Ib clinical study. Read more.
Medistim announces that they will expand their market coverage in Canada. Read more.
Se Prolight Diagnostics presentation at Stockholm Corporate Finance Life Science Capital Markets Days. Read more.
Flagging in VibroSense Dynamics has been announced following a rights issue of B shares. Read more.
Duearity has established an organization in the US ahead of the launch of the tinnitus product Tinearity G1. Read more.
Bonzun has initiated cooperation with Norrtälje municipality. Read more.
Erik Penser has analyzed ScandiDos Q3. Read more.
This morning's price development
Winner: Sprint Bioscience 14,9%, Lipigon Pharmaceuticals 14,5%, AlphaHelix 12,3%, Fluicell 11,2%, WntResearch 11,1%
Förlorare: Calmark -14,8%, Selectimmune Pharma -11,6%, NextCell Pharma -7,5%, Hamlet Pharma -6,9%, Xintela -6,3%
Index: OMXS30 2138 0,94%, Healthcare 0,24%